Literature DB >> 16219702

Statin therapy might be beneficial for patients with ankylosing spondylitis.

J C van Denderen, M J L Peters, V P van Halm, I E van der Horst-Bruinsma, B A C Dijkmans, M T Nurmohamed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16219702      PMCID： PMC1798123          DOI： 10.1136/ard.2005.044503

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

Review 1.  Beyond the laboratory: clinical implications for statin pleiotropy.

Authors:  Julian P J Halcox; John E Deanfield
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

Review 2.  The treatment of ankylosing spondylitis.

Authors:  K J Scalapino; J C Davis
Journal:  Clin Exp Med       Date:  2003-02       Impact factor: 3.984

Review 3.  Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis.

Authors:  Mike J Peters; Irene E van der Horst-Bruinsma; Ben A Dijkmans; Michael T Nurmohamed
Journal:  Semin Arthritis Rheum       Date:  2004-12       Impact factor: 5.532

4.  Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.

Authors:  David W McCarey; Iain B McInnes; Rajan Madhok; Rosie Hampson; Olga Scherbakov; Ian Ford; Hilary A Capell; Naveed Sattar
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

Review 5.  Biological therapies in the spondyloarthritides--the current state.

Authors:  J Braun; J Sieper
Journal:  Rheumatology (Oxford)       Date:  2004-06-08       Impact factor: 7.580
  5 in total
  6 in total

Review 1.  Do bisphosphonates and statins have a role in spondyloarthritis management?

Authors:  Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

Review 2.  The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in rheumatologic disorders: a comprehensive review.

Authors:  Christos G Mihos; Rosa T Artola; Orlando Santana
Journal:  Rheumatol Int       Date:  2011-07-31       Impact factor: 2.631

3.  Spondyloarthropathies: CVD prevention and statin therapy in ankylosing spondylitis.

Authors:  Anne Grete Semb; Silvia Rollefstad
Journal:  Nat Rev Rheumatol       Date:  2016-06-30       Impact factor: 20.543

Review 4.  The role of statins in neurosurgery.

Authors:  Jorge Humberto Tapia-Pérez; Martin Sanchez-Aguilar; Thomas Schneider
Journal:  Neurosurg Rev       Date:  2010-04-29       Impact factor: 3.042

5.  Rosuvastatin improves endothelial dysfunction in ankylosing spondylitis.

Authors:  Nidhi Garg; Pawan Krishan; Ashit Syngle
Journal:  Clin Rheumatol       Date:  2015-03-17       Impact factor: 2.980

Review 6.  Statins and autoimmunity.

Authors:  Saakshi Khattri; Gisele Zandman-Goddard
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.